Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genoil (GNOLF) Return on Sales (2020 - 2025)

Historic Return on Sales for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to 19.12%.

  • Genoil's Return on Sales rose 17400.0% to 19.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 68.89%, marking a year-over-year increase of 676300.0%. This contributed to the annual value of 10.75% for FY2019, which is 138500.0% up from last year.
  • Per Genoil's latest filing, its Return on Sales stood at 19.12% for Q3 2025, which was up 17400.0% from 28.46% recorded in Q2 2025.
  • Over the past 5 years, Genoil's Return on Sales peaked at 29.52% during Q4 2024, and registered a low of 36.71% during Q3 2023.
  • Its 5-year average for Return on Sales is 9.13%, with a median of 4.16% in 2021.
  • As far as peak fluctuations go, Genoil's Return on Sales skyrocketed by 885200bps in 2021, and later tumbled by -351400bps in 2023.
  • Quarter analysis of 5 years shows Genoil's Return on Sales stood at 0.37% in 2021, then rose by 23bps to 0.45% in 2022, then surged by 95bps to 0.88% in 2023, then surged by 3237bps to 29.52% in 2024, then crashed by -165bps to 19.12% in 2025.
  • Its Return on Sales stands at 19.12% for Q3 2025, versus 28.46% for Q2 2025 and 20.7% for Q1 2025.